Reckitt Benckiser Group PLC (RB.L)
8 Dec 2017
LONDON, Dec 5 Pharmaceuticals company Indivior has launched a US$485m-equivalent loan to refinance existing debt, banking sources said.
LONDON (Reuters Breakingviews) - Over-the-counter drugs could pose health risks for investors in consumer groups. Germany’s Merck has invited bids for its Seven Seas vitamins unit, while Pfizer is selling its more consumer-focused business. Nestlé and rivals see opportunities to apply their sharper marketing skills. But pumped-up valuations suggest the health drive will be expensive.
Oct 19 The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
LONDON Britain's Reckitt Benckiser will split its business into two divisions -- consumer healthcare and home and hygiene products -- to try to revive sales that are set to stall this year.
* Q3 like for like sales down 1 pct, miss estimates (Adds comments from analyst, Breakingviews link)
LONDON, Oct 18 The UK's top share index held its ground on Wednesday as third quarter earnings trickled in, with shares in Reckitt Benckiser dipping after a disappointing update.
* Reckitt benckiser ceo says seeing subdued growth in developed and developing markets
LONDON, Oct 18 Reckitt Benckiser plans to reorganise its business into two distinct units, one for health and the other for hygiene and home products, as it tries to improve its flagging performance.
A U.S. judge on Tuesday dismissed a unit of Reckitt Benckiser Group plc from a lawsuit by state attorneys general accusing it and spin-off Indivior Plc of scheming to block generic competition of the opioid addiction treatment drug Suboxone.
* JAB HOLDINGS B.V. DISCLOSES 6.69 PERCENT STAKE IN RECKITT BENCKISER GROUP PLC - REGULATORY FILING Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)